Patents by Inventor Elaine Egging

Elaine Egging has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150110784
    Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Mark A. Tomai, Gary W. Gullikson, David M. Hammerbeck, Elaine A. Egging, Michael J. Reiter, Christopher D. Gram, John P. Vasilakos
  • Patent number: 8940755
    Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: January 27, 2015
    Assignee: 3M Innovative Properties Company
    Inventors: Mark A. Tomai, Gary W. Gullikson, David M. Hammerbeck, Elaine A. Egging, Michael J. Reiter, Christopher D. Gram, John P. Vasilakos
  • Patent number: 8110582
    Abstract: The present invention provides a method of protecting a subject against UV-induced epidermal neoplasia. Generally, the method includes administering to a subject an IRM compound in an amount effective to provide protection against UV-induced epidermal neoplasia. The present invention also provides compositions that include an IRM compound in an amount effective for providing protection against UV-induced epidermal neoplasia.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: February 7, 2012
    Assignee: 3M Innovative Properties Company
    Inventors: Elaine A. Egging, David M. Hammerbeck, James H. Lee
  • Publication number: 20050226878
    Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.
    Type: Application
    Filed: June 1, 2005
    Publication date: October 13, 2005
    Inventors: Mark Tomai, Gary Gullikson, David Hammerbeck, Elaine Egging, Michael Reiter, Christopher Gram, John Vasilakos, Sefik Alkan
  • Publication number: 20050171072
    Abstract: The present invention provides therapeutic combinations that include an immune response modifier (IRM) component and an anti-inflammatory component. The inventions further provide methods of treating a condition by administering to one having the condition a therapeutic combination that includes an IRM component and an anti-inflammatory component.
    Type: Application
    Filed: December 2, 2004
    Publication date: August 4, 2005
    Inventors: Mark Tomai, Gary Gullikson, David Hammerbeck, Elaine Egging, Michael Reiter, Christopher Gram, John Vasilakos
  • Publication number: 20040175336
    Abstract: The present invention provides a method of protecting a subject against UV-induced epidermal neoplasia. Generally, the method includes administering to a subject an IRM compound in an amount effective to provide protection against UV-induced epidermal neoplasia. The present invention also provides compositions that include an IRM compound in an amount effective for providing protection against UV-induced epidermal neoplasia.
    Type: Application
    Filed: March 4, 2004
    Publication date: September 9, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Elaine A. Egging, David M. Hammerbeck, James H. Lee